![Philippe Wolgen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe Wolgen
Chief Executive Officer at
CLINUVEL PHARMACEUTICALS LIMITED
Net worth: 22 M $ as of 31/07/2026
Profile
Philippe Jacques Wolgen is Chief Executive Officer, MD & Director at Clinuvel Pharmaceuticals Ltd. since 2025 and Director at Clinuvel (UK) Ltd. since 2005.
Formerly, Chief Executive Officer, MD & Director at Clinuvel Pharmaceuticals Ltd. from 2005 to 2025.
Education includes an MBA from The Trustees of Columbia University in The City of New York, a doctorate from the University of Utrecht, and an MBA from London Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/08/2025 | 3,425,222 ( 6.79% ) | 22 M $ | 31/07/2026 |
Philippe Wolgen active positions
| Companies | Position | Start |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Chief Executive Officer | 30/09/2025 |
Clinuvel (UK) Ltd.
 Clinuvel (UK) Ltd. BiotechnologyHealth Technology Provides research and development in the field of biotechnology | Director/Board Member | 25/11/2005 |
Former positions of Philippe Wolgen
| Companies | Position | End |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Chief Executive Officer | 18/03/2025 |
Training of Philippe Wolgen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
26
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clinuvel Pharmaceuticals Ltd.
 Clinuvel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for patients with genetic, metabolic and life-threatening disorders | Health Technology |
University of Utrecht
 University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clinuvel (UK) Ltd.
Clinuvel (UK) Ltd. BiotechnologyHealth Technology Provides research and development in the field of biotechnology | Health Technology |
- Stock Market
- Insiders
- Philippe Wolgen
